The European Journal of Health Economics

Making economic evaluations more assessable to health care decision-makers

Economic burden of obesity and its complications in Germany

Beate Sander, Rito Bergemann

Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden

Jonas Lundkvist, David Bergqvist, Bengt Jönsson

Should one use smokeless tobacco in smoking cessation programs?

Mikael Bask, Maria Melkersson

A Markov model of treatment of newly diagnosed epilepsy in the UK

E. Remák, J. Hutton, M. Price, K. Peeters, I. Adriaenssen

Financial incentives and the supply of laboratory tests

Fredrik Carlsen, Jostein Grytten, Irene Skau

Health care reform in six Central European countries

Mark J. C. Nuijten, Agota Szende, Jozsef Kosa, Zsolt Mogyorosy, Boris Kramberger, Karel Nemecek, Dominik Tomek, Stjepan Oreskovic, Monika Laskowska

An exponential representation of health state utility

Michael Happich, Axel Muehlbacher

Testing assumptions of quality-adjusted life-year calculations

Ariel Béresniak

Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines

Ewa Orlewska, Piotr Mierzejewski

Modeling risk-adjusted capitation rates for Umbria, Italy

Elaine J. Yuen, Daniel Z. Louis, Paolo Di Loreto, Joseph S. Gonnella

The lag between effectiveness and cost-effectiveness evidence of new drugs

Boyka Stoykova, Michael Drummond, Marco Barbieri, Jos Kleijnen

Measles dynamics and vaccination diffusion

Laurent Coudeville

An overview of the Greek pharmaceutical market

V. Kontozamanis, E. Mantzouneas, C. Stoforos